NDC 0591-2136-55 - Propofol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-2136
- Requested NDC
- 0591-2136-55
- Package NDCs from labels
- 0591-2136-55, 0591-2136-51, 0591-2136-57, 0591-2136-68, 0591-2136-80, 0591-2136-95
- Manufacturer
- Actavis Pharma, Inc.
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propofol - Actavis Pharma, Inc. | Actavis Pharma, Inc. | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - Henry Schein, Inc. | Henry Schein, Inc. | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol | General Injectables and Vaccines, Inc. | 2018-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-2136-51 | ML - Milliliter | 0591-2136 | 0b14f2f2-28a4-4fb5-a669-08abd4efc03a | 1 | 2016-02-04 |
| 0591-2136-55 | ML - Milliliter | 0591-2136 | c7340b05-171e-42b9-9aaa-f4423b6cba5b | 1 | 2016-02-04 |
| 0591-2136-57 | ML - Milliliter | 0591-2136 | 20f74f85-7313-40e5-a1bd-99d35d50d3cd | 1 | 2016-02-04 |
| 0591-2136-68 | ML - Milliliter | 0591-2136 | 47d8a6dd-b9a7-457a-a1e8-e8e835d9157a | 1 | 2016-02-04 |
| 0591-2136-80 | ML - Milliliter | 0591-2136 | ecc8f542-06b4-4ab8-8638-70de2da9f8bd | 1 | 2016-02-04 |
| 0591-2136-95 | ML - Milliliter | 0591-2136 | 0d8814c1-098b-4f9e-8b00-4e25f3db5dc8 | 1 | 2016-02-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Signature Care Hemorrhoidal Cream (with applicator) | PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, GLYCERIN, PETROLATUM | BETTER LIVING BRANDS, LLC | b026a386-5e38-52ed-e053-2a95a90a6b0e | 2025-10-24 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2025-10-23 | Warnings | PDC6A3C0OX |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | PDC6A3C0OX |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | PDC6A3C0OX |
| Finafta | BENZOCAINE, GLYCERIN | Efficient Laboratories Inc. | 03368603-3e11-c2fa-e063-6294a90a04ea | 2025-10-14 | Warnings | PDC6A3C0OX |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 98460eae-5195-48d2-ab73-00d276879ef6 | 2025-10-09 | Warnings, Adverse reactions | 241ATL177A |
| Glycerin | GLYCERIN | H E B | 3d0566a1-57a5-6a31-e054-00144ff88e88 | 2025-10-09 | Warnings | PDC6A3C0OX |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | bdcc364b-77b2-4939-8add-03e5396d46c2 | 2025-10-08 | Warnings, Adverse reactions | 241ATL177A |
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.